Hims & Hers Stock Plunges Before Earnings: What to Watch

What happened

Hims & Hers Health shares were falling ahead of the company’s scheduled third-quarter earnings report. Analysts projected a profit of 6 cents per share and revenue of $892.89 million. In the prior quarter, sales beat forecasts, while earnings missed them.

Confirmed

Global impact / market context

The report will show whether revenue growth is continuing and whether the company has moved from last quarter’s per-share loss to the profit analysts expect. A revenue or earnings shortfall could challenge confidence in the raised sales outlook and influence investor positioning.

Analyst inference

Last quarter, revenue was $753.21 million, above the $699.89 million analyst consensus, but the company recorded a 37-cent loss per share versus an expected 3-cent loss. Subscribers reached almost 2.9 million, and management raised its 2026 sales forecast.

Confirmed

What to watch

1. Compare reported revenue with the $892.89 million forecast; a miss would weaken evidence that sales are keeping pace with analysts’ expected growth. Analyst inference
2. Check earnings per share against the 6-cent forecast; results below zero would mean a loss, rather than the profit analysts currently expect. Analyst inference
3. Look for updates on subscriber growth and the $3.1 billion to $3.3 billion 2026 sales forecast, which management raised last quarter. Confirmed

Evidence

• Original source link unavailable